Dr. Prajwal Nandekar
Dr. Prajwal Nandekar
Ph. D
Dirección de correo verificada de h-its.org - Página principal
Título
Citado por
Citado por
Año
Impact of crystal habit on biopharmaceutical performance of celecoxib
SR Modi, AKR Dantuluri, V Puri, YB Pawar, P Nandekar, AT Sangamwar, ...
Crystal growth & design 13 (7), 2824-2832, 2013
612013
Ensemble docking and molecular dynamics identify knoevenagel curcumin derivatives with potent anti-EGFR activity
IS Yadav, PP Nandekar, S Shrivastava, A Sangamwar, A Chaudhury, ...
Gene 539 (1), 82-90, 2014
412014
An ecofriendly synthesis and DNA binding interaction study of some pyrazolo [1, 5-a] pyrimidines derivatives
SS Chobe, BS Dawane, KM Tumbi, PP Nandekar, AT Sangamwar
Bioorganic & medicinal chemistry letters 22 (24), 7566-7572, 2012
302012
Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design
X Yu, P Nandekar, G Mustafa, V Cojocaru, GI Lepesheva, RC Wade
Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (1), 67-78, 2016
272016
Plasma protein binding, pharmacokinetics, tissue distribution and CYP450 biotransformation studies of fidarestat by ultra high performance liquid chromatography–high resolution …
RM Borkar, MM Bhandi, AP Dubey, PP Nandekar, AT Sangamwar, ...
Journal of pharmaceutical and biomedical analysis 102, 386-399, 2015
272015
Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings
PP Nandekar, AT Sangamwar
Expert opinion on drug discovery 7 (9), 771-789, 2012
272012
Inter-subunit interactions drive divergent dynamics in mammalian and Plasmodium actin filaments
RG Douglas, P Nandekar, JE Aktories, H Kumar, R Weber, JM Sattler, ...
PLoS biology 16 (7), e2005345, 2018
232018
Structure guided design and binding analysis of EGFR inhibiting analogues of erlotinib and AEE788 using ensemble docking, molecular dynamics and MM-GBSA
VK Sharma, PP Nandekar, A Sangamwar, H Pérez-Sánchez, SM Agarwal
RSC advances 6 (70), 65725-65735, 2016
232016
On the application of the MARTINI coarse-grained model to immersion of a protein in a phospholipid bilayer
G Mustafa, PP Nandekar, X Yu, RC Wade
The Journal of chemical physics 143 (24), 12B621_1, 2015
212015
Pregnane X receptor and P-glycoprotein: a connexion for Alzheimer’s disease management
S Jain, V Rathod, R Prajapati, PP Nandekar, AT Sangamwar
Molecular diversity 18 (4), 895-909, 2014
202014
Human pregnane X receptor: a novel target for anticancer drug development
V Rathod, S Jain, P Nandekar, AT Sangamwar
Drug discovery today 19 (1), 63-70, 2014
202014
Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction
PD Kalariya, B Raju, RM Borkar, D Namdev, S Gananadhamu, ...
Journal of mass spectrometry 49 (5), 380-391, 2014
172014
Chem-bioinformatics and in vitro approaches for candidate optimization: a case study of NSC745689 as a promising antitumor agent
PP Nandekar, KM Tumbi, N Bansal, VP Rathod, LB Labhsetwar, ...
Medicinal Chemistry Research 22 (8), 3728-3742, 2013
172013
Influence of transmembrane helix mutations on cytochrome P450-membrane interactions and function
G Mustafa, PP Nandekar, TJ Camp, NJ Bruce, MC Gregory, SG Sligar, ...
Biophysical journal 116 (3), 419-432, 2019
162019
Mechanistic insights into PEPT1-mediated transport of a novel antiepileptic, NP-647
KS Khomane, PP Nandekar, B Wahlang, P Bagul, N Shaikh, YB Pawar, ...
Molecular pharmaceutics 9 (9), 2458-2468, 2012
162012
Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations
P Pragyan, SS Kesharwani, PP Nandekar, V Rathod, AT Sangamwar
Molecular diversity 18 (4), 865-878, 2014
132014
Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations
SS Kesharwani, PP Nandekar, P Pragyan, V Rathod, AT Sangamwar
Journal of Molecular Recognition 29 (8), 370-390, 2016
122016
An evaluation of the CYP2D6 and CYP3A4 inhibition potential of metoprolol metabolites and their contribution to drug–drug and drug–herb interaction by LC‐ESI/MS/MS
RM Borkar, MM Bhandi, AP Dubey, V Ganga Reddy, P Komirishetty, ...
Biomedical Chromatography 30 (10), 1556-1572, 2016
92016
Comparative proteomics among cytochrome p450 family 1 for differential substrate specificity
SS Kesharwani, PP Nandekar, P Pragyan, AT Sangamwar
The protein journal 33 (6), 536-548, 2014
92014
Design and synthesis of optically pure 3-aryl-6-methyl-2-thioxotetrahydropyrimidin-4 (1 H)-ones as anti-prostate cancer agents
V Kumar, M Rachamalla, P Nandekar, GL Khatik, AT Sangamwar, K Tikoo, ...
RSC Advances 4 (71), 37868-37877, 2014
92014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20